Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,851–6,875 of 7,816 matching trials · page 275 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Effectiveness of Home Based Occupational Therapy for Dementia. NCT00732329 Occupational Therapy Runs in: Germany · 3 sites |
NA other |
COMPLETED | 160 | Technische Universität Dresden OTHER |
2015-02-11 |
|
Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects NCT00954252 CHF 5074; placebo; CHF 5074; CHF 5074; CHF 5074; CHF 5074; CHF 5074 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 84 | CERESPIR INDUSTRY |
2015-02-10 |
|
Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male Subjects NCT01203384 CHF5074 1x; CHF5074 2x; CHF5074 3x; Placebo Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 48 | CERESPIR INDUSTRY |
2015-02-10 |
|
Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects NCT01258452 CHF 5074; CHF 5974 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 12 | CERESPIR INDUSTRY |
2015-02-10 |
|
Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive Impairment NCT01723670 CHF 5074 1x; CHF 5074 2x; Placebo |
PHASE2 other |
WITHDRAWN | 0 | CERESPIR INDUSTRY |
2015-02-10 |
|
Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type NCT00160147 bifeprunox; Placebo Runs in: Czechia; Estonia; Israel; Poland; United States · 51 sites |
PHASE3 other |
TERMINATED | 60 | Solvay Pharmaceuticals INDUSTRY |
2015-02-09 |
|
Effect of Single-dose Dexmedetomidine on Emergence Excitement in Adults With Nasotracheal Intubation After Orthognathic Surgery NCT01524367 saline; Dexmedetomidine Runs in: South Korea · 1 site |
PHASE4 other |
COMPLETED | 74 | Yonsei University OTHER |
2015-02-06 |
|
An Observational Study for the Prevalence of Neuropsychiatric Symptom in Parkinson's Disease Dementia NCT01102582 Runs in: South Korea · 1 site |
NA other |
COMPLETED | 48 | The Catholic University of Korea OTHER |
2015-02-04 |
|
Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion NCT02353884 Runs in: China · 1 site |
NA other |
COMPLETED | 150 | XuanwuH 2 OTHER |
2015-02-03 |
|
Patients With Alzheimer Disease, Spouse Carers and Risk of Institutionalization: a Prospective Observational Cohort Study of Dyads (AID Study) NCT02351453 Runs in: France · 1 site |
NA other |
COMPLETED | 207 | University Hospital, Angers OTHER_GOV |
2015-01-30 |
|
Gait, cOgnitiOn & Decline (GOOD) NCT02350270 gait and cognitive testing Runs in: France · 1 site |
NA other |
UNKNOWN | 2,800 | University Hospital, Angers OTHER_GOV |
2015-01-29 |
|
Language Treatment for Progressive Aphasia NCT00957710 Errorless learning Runs in: Canada · 1 site |
NA other |
COMPLETED | 7 | Baycrest OTHER |
2015-01-27 |
|
Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease NCT01453569 Sodium oligo-mannurarate 600mg; Sodium oligo-mannurarate 900mg; Placebo Runs in: China · 24 sites |
PHASE2 other |
COMPLETED | 255 | Shanghai Greenvalley Pharmaceutical Co., Ltd. INDUSTRY |
2015-01-27 |
|
A Two-Part, Single-Dose Study of the Pharmacokinetics of MK-8931 in Subjects With Renal Insufficiency (MK-8931-009 [P08535]) NCT01537757 MK-8931 |
PHASE1 other |
COMPLETED | 12 | Merck Sharp & Dohme LLC INDUSTRY |
2015-01-26 |
|
A Study of Decreased Mental Function Associated With HIV NCT00027040 Selegiline hydrochloride Runs in: United States · 12 sites |
NA other |
COMPLETED | 90 | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
2015-01-16 |
|
Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease NCT00423228 ZT-1; Donepezil Runs in: Australia; Canada; United Kingdom · 28 sites |
NA symptomatic-cholinergic |
COMPLETED | 228 | Debiopharm International SA INDUSTRY |
2015-01-14 |
|
Austrian Polyintervention Study to Prevent Cognitive Decline After Ischemic Stroke NCT01109836 Motivation and lifestyle intervention Runs in: Austria · 5 sites |
PHASE4 other |
COMPLETED | 202 | Danube University Krems OTHER |
2015-01-13 |
|
Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers NCT01035164 F-18 FEDAA1106 (BAY85-8101); F-18 FEDAA1106 (BAY85-8101); F-18 FEDA... Runs in: Netherlands; Sweden · 3 sites |
PHASE1 other |
COMPLETED | 25 | Bayer INDUSTRY |
2015-01-08 |
|
Pilot Study of the Living With Hope Program for Family Caregivers of Persons With Dementia Residing in Long Term Care NCT02038192 Living with Hope Program; Stories of the Present Runs in: Canada · 1 site |
NA other |
COMPLETED | 21 | University of Alberta OTHER |
2015-01-08 |
|
LIWA for Treatment of Alzheimer Patients NCT02204969 Lithia water; Transcranial Magnetic stimulation Runs in: United States · 1 site |
PHASE1|PHASE2 other |
UNKNOWN | 100 | American Society Of Thermalism And Climatology Inc OTHER |
2015-01-06 |
|
The Influence of Oral Vibrational Stimulation on Cognitive Function of Elderly Individuals NCT02332525 Oral Vibrational Stimulation |
PHASE1|PHASE2 other |
UNKNOWN | 20 | Seoul National University Bundang Hospital OTHER |
2015-01-06 |
|
Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Mild to Moderate Alzheimer's Disease NCT01284387 ACC-001 (vanutide cridificar) Runs in: United States · 25 sites |
PHASE2 other |
COMPLETED | 126 | JANSSEN Alzheimer Immunotherapy Research & Development, LLC INDUSTRY |
2015-01-05 |
|
Telephone Resources and Assistance for Caregivers (TRAC) NCT00721383 Enhancing Physical Activity Intervention; CSBI Runs in: United States · 2 sites |
NA other |
COMPLETED | 211 | Rush University Medical Center OTHER |
2014-12-31 |
|
Ritalin, Memory and Attention in MCI: a Behaviour-EEG Study NCT02326038 Methylphenidate Runs in: Netherlands · 1 site |
PHASE4 other |
UNKNOWN | 40 | Maastricht University Medical Center OTHER |
2014-12-25 |
|
Music Therapy in Methodist Homes: a Study Investigating the Impact of a Music Therapy Programme NCT01744600 Music Therapy Runs in: United Kingdom · 2 sites |
NA other |
COMPLETED | 27 | Methodist Homes for the Aged OTHER |
2014-12-23 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial